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Abstract
Background: Malawi, Uganda, and Zimbabwe have recently adopted a universal ‘test-and-treat’ approach to the
prevention of mother-to-child transmission of HIV (Option B+). Amongst a largely asymptomatic population of
women tested for HIV and immediately started on antiretroviral treatment (ART), a relatively high number are not
retained in care; they are labelled ‘defaulters’ or ‘lost-to-follow-up’ patients.
Methods: We draw on data collected as part of a study looking at ART decentralization (Lablite) to reflect on the
spaces created through the instrumentalization of community health workers (CHWs) for the purpose of bringing
women who default from Option B+ back into care. Data were collected through semi-structured interviews with
CHWs who are designated to trace Option B+ patients in Uganda, Malawi and Zimbabwe.
Findings: Lost to follow up women give a range of reasons for not coming back to health facilities and often
implicitly choose not to be traced by providing a false address at enrolment. New strategies have sought to utilize
CHWs’ liminal positionality - situated between the experience of living with HIV, having established local social ties,
and being a caretaker - in order to track ‘defaulters’. CHWs are often deployed without adequate guidance or
training to protect confidentiality and respect patients’ choice.
Conclusions: CHWs provide essential linkages between health services and patients; they embody the role of
‘extension workers’, a bridge between a novel health policy and ‘non-compliant patients’. Option B+ offers a
powerful narrative of the construction of a unilateral ‘moral economy’, which requires the full compliance of
patients newly initiated on treatment.
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Background
Since the 1970s, the role of community health workers
(CHWs) has increasingly been recognised and forma-
lised through their contribution to public health policies
and interventions [1, 2]. A renewed focus on CHWs’ in-
volvement in public health interventions has examined
some of the important shifts in the roles of these
workers as they take on increasingly specialised tasks in
order to support overburdened health care staff, notably
in low income settings [1, 3]. More recently, a growing
number of social scientists have called for a greater em-
phasis on the evolving positionality of CHWs, and to
further explore the complex dynamics of relationships
between CHWs, patients, health care workers, and
health systems, as actors embedded in social ties and
local moral economies [4–7]. Colvin and Swartz [8] have
recently argued that CHWs have been historically
framed either as ‘extension agents’ or ‘agents of change’,
and that it is crucial to move beyond the ideals of CHWs
as either ‘tools’ to solve problems, or ‘magical objects
invested with a capacity to solve technical or political
dilemmas’ [8].
In this paper, we focus on the experience of CHWs
contributing to recent efforts aiming at preventing
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mother to child transmission of HIV (PMTCT) in low-
income countries, namely ‘Option B+’, [9] a health policy
under which pregnant and breastfeeding women are
routinely tested for HIV and immediately started on
antiretroviral treatment (ART) for life after a positive
diagnosis, regardless of an individual’s CD4 count or
WHO clinical stage [10–12]. Several studies have ex-
plored the initial impact of the implementation of this
new PMTCT strategy, [13–20] however little attention
has been paid to the experience of CHWs who play a
central part in supporting patients as well as the larger
the health system as part of these interventions.
At the onset of the implementation of Option B+,
in 2011 in Malawi, and 2013 in Zimbabwe and
Uganda, [9, 14] several public health experts voiced
concerns in relation to the challenges of retaining a
largely asymptomatic population in care on the long
term [21, 22]; A condition of the success of Option B
+ is dependent on a high proportion of patients being
retained in care. More importantly, perhaps, is the
concern around the development of resistance to
treatment if newly initiated ART patients do not
adhere to life-long treatment. In its first year of im-
plementation in Malawi, the programme had been
successful at rapidly expanding access to PMTCT ser-
vices, with a seven-fold increase in the number of
women starting ART for PMTCT, [23, 24] impacting
current efforts at expanding ART care, with most pa-
tients newly initiated at decentralized health facilities
starting ART because of Option B+, as opposed to
starting ART for their own health (i.e. because of low
CD4 counts or WHO clinical stage) [25].
The first couple of years of implementation of Option
B+ in sub-Saharan African countries have demonstrated
that women initiating ART during pregnancy have high
rates of dropout [16] and retention of women on ART
remains a challenge. Initially in Malawi, a large propor-
tion of women (17%) appeared to be ‘lost-to-follow-up’
(LTFU) six months after ART initiation, with most losses
occurring in the first three months of therapy [13].
Many women who accepted their first month of ART
never came back, raising additional questions on
whether or not they actually initiated treatment at all.
Early assessments into the reasons associated with
stopping ART amongst women who initiated treatment
during Option B+ pointed at difficulties linked to travel-
ling to health facilities and lack of transport money, not
understanding initial treatment guidance, and being too
weak, sick or experiencing treatment side effects [15].
Patients labelled as ‘LTFU’ have been portrayed as
‘threats’ to Option B+. As a result, a rapidly increasing
body of research is looking at novel strategies to retain
patients in care [26], and locate those who have been
labelled as ‘lost’ to encourage them to return into care.
‘Tracking’ HIV patients who have been labelled as ‘de-
faulters’ is not a new activity however, and a variety of
lay, community, home-based and health care workers
have previously been involved in finding patients,
counselling them and encouraging them to come back
into care to resume ART [27–29]. Within Option B+,
however, in the light of the potential risks to the
programme embodied by ‘defaulters’, the task of tracing
patients has become a crucial component of the test-
and-treat approach, and CHWs have been called upon
to find patients who have missed scheduled visits to the
health facilities.
We present data that were collected as part of a
sub-study conducted within a large three-country im-
plementation study entitled Lablite, which looked at
the decentralization of ART care in Malawi, Uganda
and Zimbabwe from 2010 onwards, during the time
that Option B+ started to be rolled out in these three
countries.
Methods
The aim of this study was to explore the range of tracing
strategies deployed in three countries that initiated Option
B+, as well as the consequences of ‘tracing’ on social
relations between CHWs and patients. Our intention is to
describe and discuss the evolving ‘positionality’ of CHWs
who are involved in a critical component of new PMTCT
programmes: the ‘tracers’, as they are commonly referred
to, who are tasked to track ‘non-compliant’ patients with
the aim of bringing them back into care. The term ‘posi-
tionality’ is used to describe how individuals are defined
by their location within shifting networks of relationships
[30] and their position (for instance in terms of power,
hierarchy, solidarity, control) [31]. In this paper, ‘position-
ality’ is conceived in relation to the ways CHWs’ roles and
identities are formed and altered through changing social
networks and relationships involving a range of local ac-
tors including, but not limited to, patients and formal
health care workers.
The study was designed around qualitative data
collection taking place simultaneously in the three
countries from December 2014 to June 2015. It was
conducted in a sub-set of five health facilities in
Malawi (Phalombe District), six in Uganda (Kalungu
and Agago districts) and four in Zimbabwe (Zvimba
district). We collected data through semi-structured
interviews with CHWs who are designated to trace
Option B+ patients in each of the Lablite sites in
Uganda, Malawi and Zimbabwe.
Study participants were identified through a purposive
sampling approach at each study site until the sample of
respondents was achieved. In each site, the research
team attempted to interview three to six individuals who
were tasked with tracing HIV patients under the Option
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B+ programme. Research participants included a range
of CHWs locally designated as Village Health Workers
(Zimbabwe), Community Health Volunteers (Uganda),
Linkage Facilitators (Uganda), Health Surveillance Assis-
tants (Malawi), and Expert Patients (Malawi). These
CHWs were purposively identified to take part in the
study because they routinely traced patients as part of
PMTCT care activities in the selected health facilities. In
total, 60 individuals (29 males, 31 females) were inter-
viewed as part of this study: Uganda n = 19 (10 males, 9
females), Malawi n = 26 (19 males, 7 females), Zimbabwe
n = 15 (2 males, 13 females).
In each country, a team of experienced social scientists
interviewed research participants. Interviews were con-
ducted at a private location within health facilities or in
a private location chosen by research participants. Each
interview lasted between 40 and 90 min. The same
semi-structured interview guides were used in the three
countries. Interview guides focused on tracing strategies,
reasons for LFTU, gender dynamics, perceptions of
CHWs and ‘tracers’, and perceptions of CHWs’ tasks. In
Uganda and Zimbabwe, direct notes, verbatim quotes
and observations were compiled in English by the inter-
viewers; due to logistical limitations it was not possible
to record interviews. In Malawi, data were recorded on
digital audio recorder in the local language (Chichewa),
and later fully transcribed and translated into English.
Data were fully anonymised and pseudonyms were used
to protect the identity of research participants.
Data analysis was conducted primarily through a deduct-
ive approach [32, 33]. A thematic framework was formu-
lated to explore issues related to tracing strategies, local
definitions of a ‘defaulter’, reasons for patient loss to follow
up, relationships with patients and health care workers,
perception of tracers and tracers’ perception of their own
job, and strategies to reduce loss to follow up. The coding
structure was applied to the data using Nvivo10. A narra-
tive account of the findings was developed from the themes
and quotes extracted from the coded data.
In the following sections, we employ the term ‘commu-
nity health worker’ as an umbrella category comprising lay
health workers who are members of the communities
where they work, who are supported by local organisa-
tions or by the national health system where they live, and
who have received a shorter training than professional
health workers [2].
Results and discussion
In the following sections, we present a summary of
the results and we discuss some of the data from in-
terviews with CHWs in the three countries. We begin
with the description of ‘defaulters’, and follow with a
discussion of the role and positionality of CHWs in
the light of this novel public health programme.
Who are the ‘defaulters’
The formal definition of a ‘defaulter’ varies by coun-
try. The epidemiological categorisation of a defaulter
designates an individual who fails to complete a
course of treatment, and often carries a negative
connotation of blame towards the patient [34]. The
term is used by health care workers and CHWs to
designate an individual who has been registered or
enrolled in a programme and who has not come
back for subsequent visits under the same initiative.
Under the Option B+ programme, and in the health
facilities where we conducted our interviews, pa-
tients were designated as ‘defaulters’ after a period
varying from one to three months (depending on the
country) from the date a patient missed a scheduled
appointment to collect ART.
In the study sites, ‘defaulters’ are identified by
health care workers who maintain large handwritten
registries to document each patient’s visit and the
date at which they are asked to come back to pick
up treatment or for additional routine tests. CHWs
work in collaboration with other health care workers
(nurses, ART clerks, clinical officers) in order to
identify ‘defaulters’ from the registers and patient
cards, which contain basic information about pa-
tients (such as the name, and sometimes the address
or village, phone number, ART card number, patient
register number).
According to recent studies conducted in Malawi [13],
and as expressed by the CHWs who we interviewed, de-
faulters under Option B+ are often younger women who
only started treatment a few weeks earlier. One of the
main reasons for women to discontinue treatment is
linked to dynamics between women who just tested
HIV-positive and their male partners. Most women en-
rolled in Option B+ were routinely tested for HIV at
their first antenatal visit. While they were seeking ante-
natal care, they found themselves offered HIV testing for
the first time, and offered to start treatment immedi-
ately. Consequently, in the three countries, CHWs pro-
vided examples pointing to the difficulties for many
women whose partner has not been tested for HIV or, if
tested positive, had not started HIV treatment:
It is culturally difficult for women to disclose such
difficult matters in as much as it is difficult for a
woman to negotiate or initiate condom use in the
marriage. So they try to keep it a secret and end up
not coming to the clinic to take their medications.
(Zimbabwe, Zvimba, BKT003).
Some women don’t come back to pick their treatment
because they fear that their husbands will ask them
why they swallow drugs every day. Some of these
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women don’t go to the clinic with their husbands so
when they are tested positive they fear to tell them,
and when they are started on treatment they again
fear to tell them that they are on drugs because their
husbands will think they are the ones who went
outside and got HIV. (Uganda, Agago, LIK005).
Men are not actively involved in this programme of
going to the hospital with their wives during the first
antenatal visit. If men were to get tested for HIV and
involved, they could be more understanding. Experience
has shown that when women receive treatment, they
do not take it in the presence of the husband. They
take it secretly because by then the husband has not
yet accepted her status. Women do not disclose their
status at times to their husbands and that is part of the
problem. (Malawi, Phalombe, NKH003).
Additional reasons were cited as contributing to
defaulting from treatment; In Malawi and Uganda, seven
of the CHWs interviewed said that complaints about the
behaviour of some of the healthcare workers had con-
tributed to patients leaving treatment; “One client
openly said she stopped taking treatment because some
health workers insulted her in front of other patients”
(Uganda, Bukukula, BUK003).
Giving birth to HIV negative children was also cited by
one CHW as another cause for loss to follow up: “After
giving birth to HIV free children they [mothers] don’t
come back for treatment. Their only aim was to have a
child without HIV, that is all” (Uganda, Kalungu, PAI004).
Another reason for stopping treatment was linked to reli-
gious beliefs and practices. One of the Malawian CHWs
commented: “when these women [enrolled in Option B+]
put their faith in prayers, they at the same time find it to
contradicting to be taking the antiretrovirals for HIV
treatment” (Malawi, Phalombe, CTK002). Other CHWs
(11 in Malawi and one in Zimbabwe) said that some
church representatives and religious leaders advised pa-
tients against taking HIV treatment: “There are some
churches which according to their doctrines don’t allow
their members to go to the hospital when they are sick,
instead they just want to pray for them. They say ‘I can’t
access ART treatment, I rely on prayers, I depend on
Jesus’.” (Malawi, Phalombe, SUH001).
In addition, in the three countries, stigma remained an
important concern for patients. They feared that accessing
treatment for HIV may jeopardize their reputation and re-
lationships with others living in the same neighbourhood:
“People are ashamed of being seen by their neighbours at
the clinic […] if you are seen in the queue, then you are
HIV-positive” (Zimbabwe, Zimba, NYA004).
A range of other reasons was given in relation to dis-
continuing treatment and not coming back to the health
facility. In Uganda and Zimbabwe, agricultural work dur-
ing the planting season was mentioned by six of the
CHWs. Other reasons included exchanging treatment
between patients, self-referrals to other health centres,
the lack of understanding of the need to take ART when
asymptomatic, side effects, alternative herbal remedies,
suspicion in relation to the validity of test results, and
the lack of privacy during visits to the health facility.
Distance between the patient’s home and the health fa-
cility, and the associated costs for transport, were also
perceived as an important deterrent to women’s contin-
ued access to HIV medication in the three countries.
Hence, to understand the complexity of the work of
those involved in tracing patients, it is crucial to recog-
nise and engage with the heterogeneous reasons that led
an individual to be labelled as a ‘defaulter’ by the system;
These vary from personal experience of being stigma-
tized, inter-personal and family dynamics, to the cost of
transport and the fear of returning to the health facil-
ities. In the next sections, we explore the strategies de-
veloped by CHWs to address some of these issues in the
context of their effort to bring patients back to care.
Plural identities
Most of the CHWs who trace patients as part of Option
B+ are not new CHWs, nor do they exclusively spend
their working time tracing patients. Instead, it is import-
ant to note that the term ‘CHW’ is used in this context
in relation to a multitude of cadres of lay and formal
health workers, as mentioned above. The distinction be-
tween lay and formal health workers is often blurred as
each cadre participates to various degrees in day to day
activities at the health centres where they are based, and
the distribution of tasks can greatly vary from one site to
another. In addition, each category of CHWs has been
set up alongside the advent of specific interventions and
health policies, and receives support from various local
and global institutions, such as government (Ministries
of Health), non-governmental organisations (especially
supporting expert patients initiatives), and global part-
nerships set up to tackle HIV/AIDS. At each study site,
lay and formal health workers constituted a heteroclite
workforce, organised and defined through varying power
dynamics and hierarchical relations between the differ-
ent cadres of healthcare workers working together. Lay
health workers, as described in other settings, [3] have
become integrated to the work of formal health workers,
especially in the context of the HIV response. The
CHWs who we interviewed also reflected these plural
identities and did not represent a homogeneous group;
they were remunerated, supervised, and supported
differently by a myriad of organisations, undertook
different training curricula, and had a distinct history of
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involvement in HIV care and treatment in the three
countries.
Many of the CHWs felt personally invested in their
work and expressed that they cared deeply for the
women and babies who they traced: “in short I can say I
am directing her [the patient’s] life” (Malawi, Phalombe,
SUH001). They took pride in contributing to "saving
lives", as they put it: “One of the most rewarding aspects
of my work has been to save the lives of patients with
HIV who had lost hope and are now up and strong
again” (Uganda, Agago, KAL002). “The biggest reward-
ing aspect of my work is that the HIV positive patients
trust and confided in me for most of their issues related
to HIV” (Uganda, Agago, KAL001).
One of the Ugandan CHWs expressed pride in her
contribution to getting a patient back into the care
system:
Sometimes when doing follow up you find some HIV
patients bedridden, discriminated and neglected by
their own families so when I help such a patient to
get her life back and to have the support from her
family I feel so proud of what I have done. I am also
happy that I act as a link between the hospital and the
community in the HIV services. (Uganda, Agago,
KAL008).
Others also expressed a renewed sense of belonging
and responsibility in their own community through tra-
cing activities: “I am now very much known in the com-
munity, I did not study a lot but at least I am valuable in
the community” (Uganda, Kalungu, BUK003).
In Malawi, many CHWs referred to themselves as
‘walking counsellors’. Because of their proximity and ac-
cess to patients’ private spaces, CHWs said that they
hold a privileged position in comparison to health care
workers who are based at the health facility:
The patients see us as their doctors; anything or any
problem they have, the person can tell us, they are
open to us […] they can be free to share with us […]
rather than for them to go to the hospital and be in a
queue [where] they feel discriminated. When they are
explaining to us they are free because they know that
this is the person who can help us even when they
come back home they say when I see my counselor
walking in the village I will be able to explain to her
the problems I am facing. (Malawi, Phalombe,
MPS003).
In Uganda, many were officially designated as ‘linkage
facilitators’: “We link the community to the hospital so
each one of their linkage facilitator here is located in the
parish or community […] this means that the mothers
you follow up in most cases know you and you know
them too” (Uganda, Agago, KAL001).
Peripheral relationships
Because of their prior or current involvements under a
variety of other initiatives, many of the CHWs involved
in this study were already part of local social networks,
and utilised these links in order to trace patients. In the
three countries, the reaction from people who were
traced was reported by CHWs as positive overall: “Most
of the women agreed to come back on HIV treatment
and assure us to come back to the health facility on the
agreed dates” (Malawi, Phalombe, CTK001).
As already noted above by the CHWs in Malawi, they
are often perceived as medical experts by their own
communities, with whom they have been working for
some time. Some patients and local inhabitants call
them ‘doctors’, in reference to their affiliation with health
facilities: “they see us as people who give them accurate
information compared to that a doctor can give”
(Malawi, Phalombe, MPS002). Sometimes, CHWs also
received gifts from the women who they visited as a
token of appreciation for their visit.
Some CHWs in Malawi and Uganda reported witnes-
sing a change in the way they were perceived locally,
which they attributed to the visible features of tracing
activities: “At first when we were starting, people were
taking us as useless people but after seeing our work
they saw that we are important people” (Malawi, Pha-
lombe, NKH003).
On the other hand, CHWs from the three countries re-
ported some tense encounters when they reached the pa-
tient who they were looking for. In Uganda and
Zimbabwe, some of the mothers who have recently tested
positive for HIV reacted with anger at being traced back
to their homes: “some women responded wildly when
asked to come back to the clinic. They shouted at me and
told me to mind about my life, not theirs” (Uganda,
Kalungu, KIR008). Younger women, especially, were
harder to convince to return for treatment, according to
some of the Malawian and Ugandan CHWs:
The most difficult group to deal with are the young
mothers. Most of these young mothers and girls don’t
want to be associated with the HIV positive people
including the health workers and us the linkage
facilitators who deal with HIV positive people. I have
witnessed some who changed their living places so as
to elude me when I am following them up. (Uganda,
Agago, KAL002).
Across the study settings, CHWs noted that women
who refuse to come back for treatment are often afraid
of being stigmatized:
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When you ask them [women] to come back to the
[health] facility, they willingly tell you ‘thanks so
much for coming and for caring about my life, I am
going to come to the clinic and continue my
treatment’. But actually very few come even after
promising that they are coming. (Uganda, Kalungu,
BUK004).
Some CHWs are openly living with HIV and referred
to themselves as ‘expert patients’. With some patients,
CHWs perceived that living with HIV helped them to
empathise with the patients’ personal difficulties of ad-
hering to treatment. Other patients were concerned with
the risk of stigma that the CHWs' visits represented if
these CHWs openly lived with HIV themselves. In
Uganda, one of the CHWs who was openly known as
living with HIV in his own village expressed: “Some pa-
tients hate me as I try to follow them up when they miss
appointments, they look at me as a messenger of stigma”
(Uganda, Agago, KAL003).
In summary, CHWs reported mixed reactions from
patients in relation to being traced back home. Some
women were grateful for the opportunity to discuss their
difficulties in taking HIV treatment. Many other pa-
tients, however, felt uncomfortable and reluctant to-
wards the repeated visits from CHWs at their homes:
“she [the patient] looks at you [the CHW] as an enemy,
as someone who has got enough time to waste visiting
her home or someone who has more than enough
money to waste buying [mobile phone] airtime to call
her” (Uganda, Kalungu, BUK003).
Through their involvement in tracing activities under
Option B+, we argue that CHWs have purposively instru-
mentalised their liminal positionality, which is situated be-
tween the experience of living with HIV (in the case of
‘expert patients’), belonging to local social networks and
sometimes representing existing networks, and being per-
ceived as a caretaker or medical specialist. In the following
section, we explore some of the strategies developed by
CHWs to ‘instrumentalise’ their liminal positionality in
the context of tracing patients.
Refining tracing strategies
In the light of the complex dilemma that they individually
face, CHWs have developed a range of individual strat-
egies to get patients back into care. In the three countries,
tracing strategies involved visiting patients at home. To do
this, CHWs need to first discuss what information is avail-
able with the health facility staff. Patients often provide a
wrong address when they are being registered, after being
tested for HIV or when asked to start HIV treatment.
Equipped with often minimal and erroneous information
about a patient’s identity and whereabouts, CHWs embark
on a daily quest to find Option B+ ‘defaulters’. In the three
countries, bicycles were the main means of transport for
CHWs, with others having no other option than walking
long distances in order to find patients.
In some cases, when a phone number was available
and the patient lived far away, some CHWs attempted
to call patients, but “we use our own personal money so
that we manage to contact the person in question”
(Malawi, Phalombe, SUH003). At times, the patient was
successfully located through phone calls to friends and
family.
In Malawi, if a CHW was not familiar with the area,
one of the first steps was often to go through the head
of a specific village, and seek permission from the chief
to visit a woman at home. CHWs observed that the vil-
lage chief seemed to be in a position to “give a lot of rea-
sons for their [women] failure to come back to the
health facility” (Malawi, Phalombe, CTK001). CHWs
also talk to other village members, neighbours, and fam-
ily members about a specific individual who has
defaulted from treatment in order to find them. In
Uganda, CHWs reported also talking to patients’ friends
at the health facility in order to locate them. “We tend
to ask around for her friends […] we ask them to tell us
why their ‘colleague’ does not come for treatment”
(Uganda, Kalungu, KIR008).
Given the nature of these strategies to trace patients,
some CHWs recognized the need to put in place proce-
dures which protect the confidentiality of patients’ seros-
tatus. Most of them said that they did not make specific
mention of HIV to others (village head, friends, family
members) when tracing patients. One CHW from
Malawi, however, expressed that confidentiality was not
as important as it once was:
There is no secret nowadays. There was
confidentiality in the past but not now as far as these
drugs are concerned. […] The people who are HIV
positive say that those who are not HIV positive are
not in fashion. [By the time they come to the health
facility], people who are on ART treatment have
already known one another (Malawi, Phalombe,
NKH004).
CHWs can spend up to three weeks chasing up a spe-
cific patient, attempting to contact them several times:
“We go again in the evening so that maybe we find them
[…] if it fails, we can go for her early that Sunday”
(Malawi, Phalombe, CTK006). Many also mentioned
that they either sent or left a message with the patient’s
family: “We may leave the message home if they are chil-
dren or her husband we get to leave the message: ‘people
from their health facility came here. They say they would
like to see you on this date. Try not to go anywhere until
they find you'.” (Malawi, Phalombe, CTK006).
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One of the Ugandan CHWs reported carrying
antiretroviral drugs to dispense them without patients
having to travel back to the health facility:
Always we carry some drugs with us when visiting
them because we are certain that when a mother
misses [a visit] to pick her drugs, they are definitely
already out of the ARVs so we can give them. […] we
make a follow up on all the patients who promised to
return to the health facility for drugs during home
visits. When one fails to follow the appointment, we
follow them up again and again until they return for
treatment (Uganda, Agago, PAI010).
When the CHWs find a patient who has defaulted,
they report carrying out one-to-one counselling which
aims at convincing the woman to come back into care
and to start treatment again. The advice provided often
went beyond adherence to treatment, as they provided
advice on relationships and talked to male partners
about testing for HIV: “we go to their home and chat
with the husband until their husband decides to come in
the open and test” (Malawi, Phalombe, CTK005).
Beyond tracing
Some CHWs reported that they threatened non-
complying patients, and continued to check on them
several months after their initial contact. In Zimbabwe,
one of the CHWs said: “I ask [to see] their medication
to make sure that they have gone to the clinic to collect
their medication and I also [do] a physical count of the
drugs. We inform the women that ‘if you don’t go to the
clinic we will report you to the [health facility] head’ and
people will eventually go to the clinic to avoid being
fined […]” (Zimbabwe, Zvimba, NYA001).
Home visits are not only necessary in some settings
where there are no other possible options to trace pa-
tients, they were also favoured by many of the CHWs as
an opportunity to check on the patients. In Zimbabwe,
one of the CHWs confided: “face-to-face is good as you
can assess the situation for yourself unlike over the
phone […] they might be lying but if you visit them in
their homes you will be able to tell if they are really sick.
Over the phone people can come up with a lot of ex-
cuses but if you visit them then they may be honest with
you” (Zimbabwe, Zvimba, NYA005).
When patients come back for treatment at the health
facility, some of the CHWs continue to actively check
on them in collaboration with nurses “to check on the
number of ARVs given so that we can ably monitor our
patients for them not to default again” (Malawi, Pha-
lombe, CTK001). They continue to follow up these pa-
tients through phone calls, and if this fails, additional
home visits. “We don’t just stop there after tracing her
[patient], we do continue following up on this person till
she starts coming to the health facility to pick up ART
and to monitor how she is taking up the antiretrovirals.”
(Malawi, Phalombe, CTK002).
In Malawi, several CHWs had set up a system to
follow-up on patients on the long term. One of them
explained:
We agree on a specific date on which they [patients]
can come [to the health facility]. When that date
comes, we go and visit them again to find out if they
have gone to the clinic. […] I check their health
passports and some would actually show me the
medicine and give me the details of their visit to the
clinics. […] It does not end there; if a woman […] is
pregnant or has just given birth, we continue giving
them home visits for some extended time up until the
baby is two years old (Malawi, Phalombe, MPS001).
Another CHW from Malawi added:
When these women come to the hospital to resume
treatment […] we request that they bring out bottles
of ARVs as evidence that they indeed resumed
treatment. We also check their health passports for
evidence of the same. […] if the woman was being
stigmatized, we ask her what the current state of
affairs is with regards to that issue of stigma (Malawi,
Phalombe, MPS002).
One of the CHWs in Malawi detailed her approach to
confronting patients who have defaulted from care:
Once we get the patient details, we go out to trace the
woman. Once found, we have to entice her until she
agrees to come back. We don’t just approach her and
ask why she has stopped taking her medication. If we
did that, she wouldn’t accept. But we talk to her
gently. We ask for her health passport, and usually
they will give it to us. As you go through the health
passport, you are looking for information as to
whether she really got tested and was found HIV
positive and whether she is indeed on treatment. Now
the women cannot refuse that the health passport
isn’t hers and at the same time, you will have found
the evidence you had been looking for (Malawi,
Phalombe, CTK003).
Some CHWs also double checked in the health reg-
isters to ensure that a woman has come back for
treatment: “we check […] the registers to see if she
really came back or maybe she just accepted [to visit
the health facility] with the aim of making us leave
her house but, from deep down, she knows that she
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will not come back” (Malawi, Phalombe, SUH001). A
strong collaboration with health facility staff enabled
CHWs to efficiently follow up each patient individu-
ally, sometimes for reasons beyond the retention in
Option B+: “We are continuously in touch with the
community coordinator at the health facility. […] We
handle adherence and social problems in the lives of
HIV/AIDS patients. We counsel them when facing
difficulties in their marriages or in their villages”
(Uganda, Agago, KAL002).
Thus, CHWs involved in tracing patients under Op-
tion B+ have developed a range of strategies for tra-
cing. Our observations in the study sites were that
CHWs often rely on their own financial resources
(phone airtime, bicycles, transport costs, time) to find
patients, and lacked supervision, guidance and train-
ing specific to the respect of patient confidentiality as
part of Option B+.
The strategies developed by CHWs, who are them-
selves pressurised to successfully bring back patients
into care, may tend to reinforce a type of support
which relies on recurrent and intimate ‘surveillance’
and monitoring of patients, at times pressurising
patients into providing medical information about
themselves, whilst remaining suspicious and threaten-
ing to report and fine those who do not comply with
the request to come back into care. Even when
patients complied to come back into care, CHWs en-
sured that they actively followed up prior defaulters
for up to two years. Some of these strategies can
seem problematic in relation to the respect of the
privacy and confidentiality of patients who may have
implicitly opted out from Option B+ by providing
erroneous contact details at registration.
Limitations
Several limitations must be noted in relation to our
approach. The data collected were cross-sectional
and limit our ability to describe changes in the posi-
tionality of CHWs over time and in relation to the
evolution of the implementation of Option B+. In
addition, the data presented in this paper are limited
to a few sites in each country and comprise inter-
views with diverse cadres of CHWs (village health
workers, expert patients, community health workers,
health surveillance assistants). As noted in the paper,
each of these cadres of CHWs have a different
history and function, and we recognise the need to
explore in more depth how these different functions
and identities affect or influence the actual tasks and
perception around tracing activities. Furthermore,
despite having selected our study sites with the
Lablite team with the intention of including sites which
are representative of the current decentralization of ART
in the three selected countries, we acknowledge that the
views and opinions presented in this paper are not repre-
sentative of all CHWs in these sites and we have tried as
much as possible to indicate to what extent each of the
views of CHWs were shared amongst the individuals who
participated in the study.
Conclusion
In this paper, our intention was to explore some of the
recent shifts in the positionality of CHWs that have
accompanied the implementation of Option B+ and its
patient tracing activities. Our approach illustrates how
low retention into care and non-compliance to ART are
envisaged as threats, not only to the future success of
the implementation of this large public health policy,
they also jeopardize the treatment outcomes of popula-
tion groups if new resistance strains to current antiretro-
virals were to develop.
Our findings point at similar shifts in the three
countries; CHWs who are tasked to trace ‘defaulters’
as part of Option B+ have developed strategies to
utilise their liminal positions and identities. On the
one hand, they provide essential linkages between
health services and patients as they embody the role
of ‘extension workers’. Our study attests to the shifts
in the role of CHWs described by Kalofonos and
Maes as well as others, where CHWs take on the
functions of community management, surveillance
and reporting of desirable as well as unacceptable be-
haviours [6, 35]. Here, the role of CHWs as ‘exten-
sion workers’ has become conflated with the creation
of uncomfortable spaces through the responsibility of
bringing back ‘non-compliant’ patients into care.
Yet, the same CHWs also represent a symbolic and oper-
ational thread, bridging a novel and quasi-experimental
health policy with its main threat, embodied through the
non-compliant patients, the ‘defaulters’. In this instance, as
Moyer [36] observed in a different context, monitoring and
adherence become collective rather than individualized
practices [36], contributing, as she put it, to what Nguyen
[37] described as an assemblage of pharmaceuticals,
services, and surveillance tools [37].
Given the underlying complexities and individual
reasons that lead one to ‘default’ from treatment, we
question the over-reliance on CHWs, as well as the
lack of support they receive, to address what is con-
ceptualised as a ‘threat’ to Option B+. Against the
backdrop of a successful and wide-reaching health
policy, the act of ‘tracing’ and checking on patients
attests to the materialisation of ‘moral contracts’, that
is “a set of tacit and explicit expectations underlying
relationships between actors involved in the global
care continuum” [7]. As CHWs become “front-line
care providers at the ‘interface’ between large-scale
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policy aspirations and local programme implementa-
tion, they also become invested with a liability to
comply with model targets and operate within more
complex, technical systems of care” [7].
A thorough review of the processes involved in test-
and-treat processes, including the lack of time and space
for patients to make decisions about their own care is
urgently needed, as we argue in a separate paper [38].
Option B+ offers a powerful narrative of the construc-
tion of a unilateral ‘moral economy’, which requires the
compliance of patients who are newly initiated on treat-
ment. In this context, decision-making and therapeutic
choice is often negated from patients themselves and
CHWs have become liable to make these decisions on
behalf of the patients who they are trying to get back
into care.
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